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The regulators of calcineurin (RCAN) proteins, previously known as calcipressins, have been considered to be a well conserved family from
yeast to human based on the conservation of their FLISPP motif. Here, after performing a RCAN comparative genomic analysis we propose the
existence of a novel functionally closely related RCAN subfamily restricted to vertebrates, the other RCAN proteins being considered only as
distantly related members of the family. In addition, while three paralogous RCAN genes are found in vertebrates, there is only one in the other
members of Eukarya. Moreover, besides the FLISPP motif, these paralogous genes have two others conserved motifs, the Cn-inhibitor RCAN
(CIC) and the PxIxxT, which are restricted to vertebrates. In humans, RCAN1 and RCAN2 bind and inhibit Cn through their C-terminal region.
Given the high amino acid identity in this region among human RCANs, authors in the field have hypothesized a role for RCAN3 in inhibiting Cn
activity. Here, we demonstrate for the first time that human RCAN3, encoded by the RCAN3 (also known as DSCR1L2) gene, interacts physically
and functionally with Cn. This interaction takes place only through the RCAN3 CIC motif. Overexpression of this sequence inhibits Cn activity
towards the nuclear factor of activated T cells (NFAT) transcription factors and down-regulates NFAT-dependent cytokine gene expression in
activated human Jurkat T cells.
© 2007 Elsevier B.V. All rights reserved.Keywords: RCAN3; Calcineurin; Cytokine; DSCR1L2; NFAT; Immunosuppression1. Introduction
Calcineurin (Cn; also known as PP3C, formerly PP2B), the
unique Ca2+/calmodulin-activated serine/threonine phospha-
tase, is a key enzyme that links Ca2+ extracellular signals to
transcriptional activation of many target genes. This enzyme is
involved in multiple cellular processes, among them T-cell
activation [1]. Cn activation upon an intracellular Ca2+
increase leads to dephosphorylation of its substrates, including
the NFATs (NFAT 1–4) transcription factors. Once dephos-
phorylated, NFATs translocate to the nucleus, where, in
cooperation with other transcription factors such as AP-1,
MEF2 and GATA, they induce gene expression of target genes,
including cytokine genes in human T cells which regulate the
immune response [2–4].⁎ Corresponding author. Tel.: +34 93 2607339; fax: +34 93 2607414.
E-mail address: mpr@idibell.org (M. Pérez-Riba).
0167-4889/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2006.12.007Nowadays, the main target in immunosuppression for
transplant therapy and autoimmune diseases treatment is the
inhibition of Cn activity by cyclosporine A (CsA) and
FK506, administrated alone or in combination with other less
specific drugs [5]. Unfortunately, prolonged treatment with
these anti-calcineurinic drugs, which require binding to
cytosolic immunophilins and promote a sustained and
ubiquitous Cn phosphatase inhibition, produce major side
effects. Thus, it is essential to find and characterize novel
immunosuppressants, more specific and with fewer side
effects than the current ones. In this respect, an effort to
determine Cn endogenous inhibitors has led to the identifica-
tion of several proteins [6], including the members of the
RCAN family [7]. In humans, the RCAN family includes
RCAN1 (also known as calcipressin 1 or CALP1/ADAPT78/
DSCR1/MCIP1) encoded by the RCAN1 (previously
DSCR1) gene [8,9], RCAN2 (also ZAKI-4/CALP2/
DSCR1L1/MCIP2) encoded by the RCAN2 gene [10] and
RCAN3 (also CALP3/DSCR1L2/MCIP3) encoded by the
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tee has recently accepted this novel denomination for RCAN
proteins and genes [12].
It has been described that human RCAN1 and RCAN2
physically bind to and inhibit the phosphatase activity of Cn. As
a consequence, NFAT nuclear translocation is abrogated [13–
15] and NFAT-dependent downstream events become down-
regulated [16], suggesting a novel role for these proteins in
inhibiting the immune response. The high amino acid identity at
the central and C-terminal regions among the three human
RCANs has led authors in the field to predict an inhibitory role
for RCAN3 in Cn signalling.
The human RCAN3 gene was predicted in silico on the basis
of its sequence homology with the other two human gene
homologues, RCAN1 and RCAN2 [11]. The mouse orthologous
Rcan3 gene has also been predicted [17]. The human RCAN3
gene localizes on chromosome 1p36.11 and consists of five
exons [18]. This gene is expressed in heart, skeletal muscle,
liver, kidney and peripheral blood leukocytes [11]. Three
RCAN3 transcripts are generated by alternative splicing which
gives rise to three RCAN3 protein isoforms. The RCAN3
isoform 1 (RCAN3-1) is predicted to have 241 amino acids and
a molecular weight of 27.5 kDa. The RCAN3 isoform 2
(RCAN3-2) has an in-frame loss of 10 amino acids in the
middle of the predicted protein [11], and recently, the RCAN3
isoform 3 (RCAN3-3) has been identified, which is encoded by
exons 2 and 5, and shows a frame shift in the amino acid
sequence of exon 5 giving rise to an isoform with a different C-
terminal region [18]. To date no functional role has been
reported for RCAN3 besides its interaction with the human
cardiac troponin I [18].
The functional characterization of the RCAN1 has revealed
that several RCAN1 motifs could be involved in the Cn-NFAT
signalling modulation: FLISPP, considered to date as the
signature of the RCAN family, ELHA-including CIC (for Cn
inhibitor RCAN motif) and PxIxxT. Phosphorylation of the two
serine residues within the FLISPP motif correlates with
modulation of the Cn activity [19,20] and decrease of the
RCAN1 half-life [19]. Furthermore, our group has recently
described two independent Cn binding sites for RCAN1, the
ELHA and the PxIxxT motifs, both localized in the RCAN1 C-
terminal region [16]. The RCAN1 28 amino acid residues CIC
motif, which contains the ELHA Cn-binding sequence, inhibits
NFAT-dependent cytokine gene expression in human T cell
lines and, therefore, T cell activation [16].
The present study shows a comparative genomic analysis
that lead us to propose that RCANs in vertebrates form a novel
subfamily whose members are likely to be more closely
functionally conserved, with other RCAN forms being
considered as distantly-related members of the family. More-
over, the RCANs CIC motif is restricted to vertebrates. On the
other hand, our experimental results clearly show that RCAN3
physically interacts with Cn. This binding occurs through its
CIC motif, which inhibits the NFAT-dependent cytokine gene
expression in human cultured T cells. Therefore, we hypothe-
size an emerging function for RCAN3 in inhibiting the immune
response.2. Materials and methods
2.1. Comparative genomic and multialignment analysis
All recognizable RCAN homologues were obtained by BLAST [21]
searches from 40 eukaryotic genome projects by using ENSEMBL genomes,
NCBI genomes, Integr8 portal maintained by the European Bioinformatics
Institute (EBI), Sanger Institute, Center for the Study of Biological Complexity
(CSBC), The Institute for Genomic Research (TIGR), BROAD Institute, The
Josephine Bay Paul Center in Comparative Molecular Biology and Evolution
(JBPC), Joint Genome Institute (JGI) and Cyanidioschyzon merolae Genome
Project. The eukaryotic genomes analyzed are: Homo sapiens, Pan troglodytes,
Canis familiaris, Bovis taurus, Mus musculus, Rattus norvegicus, Gallus
gallus, Tetraodon nigroviridis, Danio rerio, Takifugu rubripes, Xenopus
tropicalis, Ciona intestinalis, Anopheles gambiae, Drosophila melanogaster,
Apis mellifera, Caenorhabditis elegans, Caenorhabditis briggsae, Saccharo-
myces cerevisiae, Schizosaccharomyces pombe, Candida glabrata, Enta-
moeba histolytica, Yarrowia lipolytica, Aspergillus fumigatus, Neurospora
crassa, Cryptosporidium hominis, Oryza sativa, Arabidopsis thaliana, Giar-
dia lamblia, Cryptococcus neoformans, Debaryomyces hansenii, Encephali-
tozoon cuniculi, Eremothecium gossypii, Kluyveromyces lactis, Phanerochaete
chrysosporium, Thalassiosiria pseudonana, Dictyostelium discoideum, Plas-
modium falciparum, Plasmodium yoelii, Leishmania major and Cyani-
dioschyzon meroale. The multialignment analysis of the central and C-
terminal regions of RCANs (corresponding to exons 3, 4 and 5 for RCAN3)
were analyzed by ClustalX [22] and refined manually with MEGA version 3.1
[23] and GeneDOC [24]. Insertions and sequence characters that could not be
aligned with confidence and incomplete sequences were removed. The final
alignment included 38 taxa.
2.2. Phylogenetic tree
The alignment used for the phylogenetic tree included 30 taxa and was
created using ProtTest [25]. ProtTest selects the most appropriate model of
protein evolution among 64 different ones based on the smallest Akaike
Information Criterion or Bayesian Information Criterion score. This software
takes advantage of the PAL library [26] and of the Phyml program [27]. The
best-fit model of protein evolution for the RCAN protein family according to
ProtTest corresponds to a JTT model with a different evolution rate among
sites (+G). MEGA 3.1 software was used in order to obtain the Neighbour
Joining consensus tree with bootstrap values after 500 replications.
2.3. Semiquantitative RT-PCR
Jurkat cells were stimulated with 1 μg/ml anti-CD3 plate-bound and 1 μg/ml
anti-CD28 soluble (Sigma-Aldrich Co., St. Lois, MO) for up to 6 h. RNA was
purified, reverse transcribed using the Superscript II enzyme (Invitrogen
corporation, Carlsbad, CA), and the resulting cDNA was amplified by PCR
varying the number of cycles to ensure being at exponential phase. PCR
conditions were initiated with a cycle of 5 min at 94 °C followed by 26 cycles of
94 °C 30 s, 58 °C 30 s, 72 °C 30 s and a final elongation of 72 °C for 7 min.
Samples were resolved in a non denaturing 6% PAGE and visualized by silver
staining. Primers sequences were for RCAN3 cDNA sense: 5′-CGTA-
GAATTCTGCTGAGGGACACTATG-3′ and antisense: 5′-GGTACTTAA-
GTCACAGCGCGCAATCAAAGG-3′; for RCAN1-4 sense 5′-CCCTGATTG-
CCTGTGTGG-3′ and antisense 5′-AGTCTTATGCAGCTGGAGC-3′ and
for GAPDH sense: 5′-GGTGAAGGTCGGAGTCAACG-3′ and antisense:
5′-CAAAGTTGTCATGGATGACC-3.
2.4. Cloning of the human RCAN3 gene
Peripheral blood leukocytes were purified from healthy human blood
samples (Ficoll-Paque, Amersham Biosciences, Uppsala, Sweden) and 2 μg of
total RNA was reverse transcribed. The human RCAN3 cDNA was amplified
by using the human RCAN3 primers indicated above. PCR conditions were:
5 min at 94 °C, 30 cycles of amplification for 30 s at 94 °C, 30 s at 60 °C and
30 s at 72 °C and a final elongation step of 72 °C for 5 min. DNA sequencing
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accession no. AF176116, which gives rise to the RCAN3-1 isoform (hereafter
referred to as RCAN3).
2.5. Expression plasmids
Full length and truncated RCAN3 constructs were amplified by PCR
using specific primers and then cloned into the pGEM-T Easy vector
(Promega, Madison, WI). cDNA inserts were ligated into the EcoRI site ofthe pGEX-5X vector (Amersham Bioscience) and of pEGFP (Clontech, Palo
Alto, CA). The RCAN3 cDNA was subcloned as an N-terminal
haemagglutinin (HA)-tagged fusion in the pCDNA3-HA vector [14]. The
pHA-NFAT-EYFP (hereafter denominated as NFAT-EYFP) has been
previously described [16]. All constructs generated were confirmed by
DNA sequencing. The pGEX6P-hCnAα (2–389) encodes for the GST-
human CnA isoform α (amino acids 2–389) and is referred to hereafter as
GST-Cn [28]. The 3xNFAT-luc, 6xNF-κB-luc, pEGFP and pEGFP-p65
plasmids were previously described [29,30].
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Jurkat clone E6-1 (human acute T cell leukaemia), COS-7 (monkey
African green kidney) and HeLa cells (human cervix carcinoma) were
grown as previously described [16]. HEK 293T (human embryo kidney)
cells were grown in DMEM (Invitrogen Corporation) supplemented with
10% (v/v) FBS, 100 units/ml penicillin, 100 μg/ml streptomycin and 2 mM
glutamine.
2.7. Binding assays
Full length and truncated GST–RCAN3 and GST-Cn fusion proteins or
GST were expressed and purified following pGEX manufacturer's instruc-
tions. Full length and truncated pEGFP–RCAN1-1 (RCAN1-1, hereafter
referred as RCAN1 corresponds to the CALP1L protein previously described
[16]) and pEGFP–RCAN3 plasmids (15 μg each) were transfected by the
calcium phosphate method [31] in HEK 293T cells and grown for 48 h at
37 °C 5% CO2. HeLa soluble protein extracts and binding assays were
processed as described previously [16]. Soluble protein extracts from cells
expressing EGFP fusion proteins were pulled down with GST or GST-Cn
and analyzed by Western blot with anti-GST (Amersham Biosciences) and
anti-GFP (Santa Cruz Biotechnology, Santa Cruz, CA) antibodies. The
signals were visualized with enhanced chemiluminescence (ECL) detection
reagent (Amersham Biosciences) using the VersaDoc 5000 imager (Bio-Rad,
Hercules, CA).2.8. Immunofluorescence
COS-7 cells were co-transfected by the DEAE-dextran method [32] with
1 μg of each full length and truncated pEGFP–RCAN3 and pHA-NFAT-EYFP
[16] constructs. Then, cells were stimulated for 10 min with 1 μM ionomycin
(Io), fixed and visualized by confocal microscopy, as previously described [16].
EGFP and EYFP fusion proteins were visualized using the 488 nm lane and the
514 nm lane respectively of the Argon laser of the Ar/He Ne confocal
microscopy (Leica DMIRBE, Heidelberg, Germany). This work was performed
at the Confocal Microscopy and Cellular Micromanipulation Unit belonging to
the Technical Scientist Service at the Universitat de Barcelona.
2.9. Luciferase assays
HEK 293T cells (6×104) were seeded on 12-well plates and transiently co-
transfected with the pCDNA3-HA (150 ng) or pCDNA3-HA-RCAN3 (15 and
150 ng) constructs, the pCMV-βgal (0.5 μg) plasmid and with the 3×NFAT-luc
(0.5 μg) or the 6×NF-κB-luc (0.5 μg) reporter plasmids. In the NF-κB assays,
cells were also co-transfected with the pEGFP (100 ng) or the pEGFP-p65
(100 ng) plasmids. The pCMV-βGal plasmid was used as internal control of
transfection efficiency [19]. 24 h post-transfection, NFAT promoter activation
was measured in cells stimulated with 1 μM Io, 20 nM phorbol 12-myristate 3-
acetate (PMA, Sigma-Aldrich) and 10 mM CaCl2 for 8 h. When indicated, 1 μM
CsA (Novartis, CH) was added 2 h prior to calcium stimulation. Lysates were
prepared using the luciferase assay system (Promega) following manufacturer's
instructions and analyzed by using a TD-20/20 luminometer (Turner
Biosystems, CA). Luciferase units were normalized for β-galactosidase activity.
Promoter fold activation values correspond to the ratio between each sample and
the unstimulated control empty vector normalized luciferase activities. At least
three independent experiments were performed in triplicate.
2.10. Real-time PCR
Jurkat cells were electroporated (40 μg DNA per 20×106 cells) at 260 V/
1050 μF (Electro Cell Manipulator 630, BTX, San Diego, CA) and cellsFig. 1. Phylogenetic and comparative genomic analysis of the RCAN family
members. (A) The FLISPP motif is conserved in the Eukarya whereas the CIC
and the PxIxxT motifs are restricted to vertebrates. Schematic representation of
the Eukarya lineage including the 40 taxa analyzed: HS, Homo sapiens; PT, Pan
troglodytes; BT, Bovis taurus; CF, Canis familiaris; MM, Mus musculus; RT,
Rattus norvegicus; GG, Gallus gallus; XT, Xenopus tropicalis; FR, Takifugu
rubripes; DR, Danio rerio; TN Tetraodon nigroviridis; CI, Ciona intestinalis;
CE,Caenorhabditis elegans; CB, Caenorhabditis briggsae; AM, Apis mellifera;
DM, Drosophila melanogaster; AG, Anopheles gambiae; CN, Cryptococcus
neoformans; PC, Phanerochaete chrysosporium; AF, Aspergillus fumigatus;
YL, Yarrowia lipolytica; NC, Neurospora crassa; DH, Debaryomyces hansenii;
AGo, Eremothecium gossypii; KL, Kluyveromyces lactis; CG, Candida
glabrata; SC, Saccharomyces cerevisiae; SP, Schizosaccharomyces pombe;
EC, Encephalitozoon cuniculi; DD, Dictyostelium discoideum; LM, Leishma-
nia major; EH, Entamoeba histolytica; CH, Cryptosporidium hominis; PF,
Plasmodium falciparum; PY, Plasmodium yoelii; GL, Giardia lamblia; AT,
Arabidopsis thaliana; OS, Oryza sativa; TP, Thalassiosiria pseudonana; CM,
Cyanidioschyzon meroale. The paralogous RCANs in vertebrates, RCAN1,
RCAN2 and RCAN3 proteins are shown in columns. The presence of the
FLISPP, the CIC and the PxIxxT motifs is indicated in red, blue and yellow,
respectively. Absence of coloured boxes means that the sequence was not found.
(B) RCAN3 and RCAN2 are phylogenetically more closely related than
RCAN1. The ProtTest program created a neighbour joining tree with JTT as a
distance matrix (see Materials and methods). RCAN3, RCAN2 and RCAN1
paralogous are boxed separately in red, green and blue, respectively. Numbers
correspond to bootstrap values over 60% reached after 500 replications. Species
analyzed were: human, HS; chimp, PT; dog, CF; mouse, MM; rat, RT; chicken,
GG; frog, XT; tetra, TN; fugu, FR, and zebra, DR. The fly, DM, and honeybee,
AM, RCAN proteins have been included in the phylogenetic tree in order to
show the RCAN1, RCAN2 and RCAN3 divergence inside the vertebrate lineage
and not before. The scale length indicates 0.1 substitutions per site.
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by FACS (BD FACSAria Flow Cytometer, Becton Dickinson Biosciences, San
José, CA) at the Fundació per a la Recerca, Hospital Universitari Vall d'Hebron,
Barcelona. Then, cells were stimulated for 3 h 30 min with 1 μM Io and 20 nM
PMA in the absence or presence of 1 μM CsA 30 min prior the stimuli. A low-
density array (Micro Fluidic cards) was performed analyzing 2 ng of cDNA per
each PCR reaction in the ABI PRISM® 7900HT Sequence Detection System
(Applied Biosystems, Foster City, CA), as reported previously in detail [16].
Gene expression data were normalized against endogenous controls, GAPDH
and 18S ribosomal gene, obtaining equivalent results although only those
corresponding toGAPDH are indicated in the text. Then, results were referred to
the EGFP Io+PMA sample considered as the 100% value and the calibrator
sample. Taqman probes used for GAPDH and cytokines IFN-γ, TNF-α, IL-2
and IL-3 genes had been previously described [16]. The corresponding probes
for the 18S ribosomal and RCAN1 genes were 4342379 and Hs00231766_m1,
respectively. This work was performed at the Genomic Unit of the Technical
Scientific Service at the Universitat de Barcelona.3. Results
3.1. RCANs amino acid conservation in vertebrates defines a
novel RCAN subfamily
The RCANs have been considered to be a well conserved
family from yeast to human based on the conservation of their
FLISPP motif which, to date, has been recognized as the
signature of the family [33]. Here we present a comparative
genomic analysis that includes 40 taxa. As can be observed,
the major identity among Eukarya is restricted to the FLISPP
motif (Fig. 1A, FLISPP motif in red). This motif is not present
in Plants, Algae, several fungi and most protozoa (Fig. 1A). It
is noteworthy that parasites do not have the FLISPP motif
(Fig. 1A, see EC, LM, EH, CH, PF, PY and GL). Those
proteins having regions of similarity covering more than 50%
of the query sequence were considered homologues. The
RCAN proteins in vertebrates are highly conserved whilst
RCANs in fungi, insecta, nematode and chordates excluding
vertebrates have regions of similarity covering less than 50%
of the query sequence, being included in this family because
they share the FLISPP motif. It is also noticeable that
protozoa, fungi and invertebrates only have one RCAN
protein whereas vertebrates present three members (Fig. 1A).
All these data point to the existence of a novel RCAN
subfamily restricted to vertebrates.
In vertebrates, the amino acid sequence of the three RCANs
differ in their N-terminal region, but it is highly conserved at
their central and C-terminal regions encoded by exons others
than the first one (Supplementary Fig. 1). These data argue for
the monophyletic cluster of RCAN1, RCAN2 and RCAN3
proteins in vertebrates. The RCANs common region in
vertebrates includes the three motifs characterized to date in
this family, which are FLISPP, CIC and PxIxxT (Fig. 1A, in red,
blue and yellow, respectively). The RCAN2 amino acid
sequence in Takifugu rubripes and Tetraodon nigroviridis
were not found in the genome projects analyzed (Fig. 1A, see
FR and TN). As can be observed, unlike the FLISPP motif
conservation in the Eukarya, the CIC motif is restricted to the
vertebrates and seems to be present in the three RCANs. This
motif is more conserved between RCAN2 and RCAN3 thanwith RCAN1 (Supplementary Fig. 1), but its functional
relevance in RCAN2 and RCAN3 still needs to be addressed.
Furthermore, as occurs with the CIC motif, PxIxxT is only
present in vertebrates. A detailed analysis of these sequences in
RCAN vertebrates shows that this PxIxxT motif is conserved in
RCAN1 and RCAN2 proteins but not in the RCAN3 members
(Supplementary Fig. 1). As an exception in invertebrates, the
RCAN in Apis mellifera includes a consensus PxIxxT motif but
not in the fly (Fig. 1A, compare AM vs. DM). More surprising
is the lack of any RCAN in mosquito (Fig. 1A, see AG). Thus,
Cn-binding through this motif in Apis mellifera needs to be
approached.
Further analysis of the RCANs central and C-terminal
regions in vertebrates reveals high amino acid conservation
outlying the FLISPP, CIC and PxIxxT motifs (Supplementary
Fig. 1, conserved amino acids in shades of grey). It can be easily
observed that some residues are characteristic and/or exclusive
for each RCAN1, RCAN2 or RCAN3 protein (Supplementary
Fig. 1, in blue, green and red, respectively). Moreover, there is
higher amino acid conservation between RCAN2 and RCAN3
with respect to RCAN1 (Supplementary Fig. 1). These data are
also supported by the RCANs phylogenetic tree in vertebrates
that shows that RCAN2 and RCAN3 are more homologous
between them than with RCAN1 (Fig. 1B).
3.2. RCAN3 gene expression is not regulated upon an
intracellular Ca2+ increase
Taking into account that Cn plays a crucial role in immune
response and that RCAN3 has been postulated as a Cn
regulatory protein, we decided to verify if RCAN3, as well as
RCAN1, would play a role in this signalling pathway. As a first
step in this direction we confirmed that the RCAN3 gene is
expressed in human peripheral blood leukocytes [11] by RT-
PCR amplification using specific primers. The 726 bp PCR
product amplified was cloned and its cDNA sequence
corresponded to the RCAN3-1 protein isoform (referred here
as RCAN3). The analysis of the 1.2 Kb 5′-flanking region of
the human RCAN3 gene (NCB accession no. AL034582)
showed the presence of several putative transcription factor
binding sites, including three consensus NFAT binding
sequences (T/AGGAAANA/T/C) [34]. To determine if Ca2+
and Cn regulate RCAN3 gene expression, Jurkat cells were
stimulated with anti-CD3/anti-CD28 antibodies that trigger T
cell receptor activation (Fig. 2A). No significant change in
RCAN3 transcription levels was observed (Fig. 2A, RCAN3
panel, compare stimulated lanes vs. basal lane). Identical results
were obtained when Jurkat cells were stimulated with Io
+PMA. Likewise, addition of CsA or FK506 did not inhibit
RCAN3 gene expression (data not shown). As a control,
RCAN1-4 gene expression, whose promoter has a dense cluster
of fifteen NFAT binding consensus sites, showed regulation by
Ca2+ as reported [16,35,36] (Fig. 2A). Thus, our results suggest
that those predicted NFAT consensus binding sites on the
putative RCAN3 promoter are not likely to be functional sites
under our experimental conditions. In this respect, Rao et al.,
reported that synergistic interactions among several NFAT-
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[34].
All these results point to RCAN3 gene expression not being
regulated by an intracellular Ca2+ increase in Jurkat cells but
also that this gene is not under the physiological regulation of
Cn activity.
3.3. RCAN3 interacts with Cn through the CIC motif
Given that RCAN1 and RCAN2 interact with Cn and their
interacting RCAN region is highly conserved in all RCANs, we
decided to check if RCAN3 binds to Cn. Soluble protein
extracts obtained from HEK 293T cells overexpressing full
length EGFP–RCAN3 were subjected to GST-Cn pull down
assays (Fig. 2B). Full length RCAN1 fused to EGFP was usedas a positive control for Cn binding and EGFP–RCAN1 2–172
as a negative one since its sequence includes the consensus
FLISPP motif but lacks the Cn-interacting RCAN1 motifs [16].
All EGFP fusion proteins are detected in each corresponding
input lane (Fig. 2B, WB αGFP, lanes 1 to 3 and 7). Furthermore,
it can be observed that EGFP–RCAN3 clearly interacts with
GST-Cn but not with GST (Fig. 2B, WB αGFP and αGST, lane
6 and lane 9 vs. 8). To better characterize the RCAN3 amino
acid sequence involved in Cn-binding, we generated several
constructs encoding the full length and truncated GST–RCAN3
fusion proteins (Fig. 2C), which were analyzed by pull down
assays. The integrity of all fusion proteins was confirmed by
Western blot analysis (Fig. 2D, WB αGST). Pull down assays
using HeLa soluble protein extracts as a source of Cn showed
that endogenous Cn interacts with full length GST–RCAN3
whereas it does not interact with GST (Fig. 2D, WB αCnA,
compare lane 2 vs. lane 1). Further analysis with truncated
GST–RCAN3 fusion proteins demonstrated that the RCAN3 C-
terminal region, as occurred with RCAN1 [16], pulled down
endogenous Cn whereas neither its N-terminal nor its central
region, that includes the FLISPP motif, did (Fig. 2D, WB
αCnA, compare lane 5 vs. 3 and 4). The analysis of smaller
GST–RCAN3 C-terminal fusion proteins revealed that RCAN3
210–241, which contains the PxIxxT-like sequence QKIAQT,
does not bind Cn (Fig. 2D, WB αCnA compare lanes 9 vs. 8).
Then, the RCANs previously described PxIxxT consensus
sequence [16], which resembles the docking NFAT PxIxIT site
for Cn that allows NFAT dephosphorylation but it is also
characteristic of several endogenous Cn inhibitors, is notFig. 2. RCAN3 interacts with Cn through the CIC motif. (A) Endogenous
RCAN3 gene expression is not regulated by activation of the T cell receptor in
human Jurkat cells. Semiquantitative RT-PCR experiments were performed with
Jurkat cells stimulated or not with 1μg/ml anti-CD3 and 1μg/ml anti-CD28 at
the indicated times. Total RNA (1 μg) was reverse transcribed and amplified
with specific primers. The size of the PCR products obtained were for GAPDH,
497 pb; for RCAN3 726 pb and for RCAN1-4, 189 pb.GAPDHmRNAwas used
as the internal control for sample normalization (upper panel) and RCAN1-4
mRNA as a Ca2+-responsive positive control (lower panel). (B) RCAN3 binds to
Cn. Western blot analysis of GST or GST-Cn pull down assays performed in
HEK 293T cells expressing EGFP–RCAN1 2–172, EGFP–RCAN1 and
EGFP–RCAN3 fusion proteins. Full length RCAN3 and RCAN1 are shown
in all figures as RCAN3 and RCAN1. Each EGFP fusion protein is indicated in
its corresponding lane. Lanes 1 to 3 and 7 correspond to inputs. Lanes 4 to 6 and
9 correspond to GST-Cn pull down lanes whereas lane 8 corresponds to GST
pull down control. Immunodetection of the interaction was performed with anti-
GFP (WB αGFP, upper panel) and anti-GST (WB αGST, lower panel). The
results shown here are representative of three independent experiments. (C)
Schematic diagram of the GST–RCAN3 fusion proteins analyzed. Numbers
refer to the RCAN3 amino acid sequence they span (NCB accession no.
AAF01684). The RCAN3 FLISPP (striped box) and CIC (grey box) motifs are
also shown. The ability of each GST–RCAN3 fusion protein to interact or not
with Cn is indicated by + or −, respectively. (D) The RCAN3 CIC motif
mediates the interaction with Cn. Western blot analysis of pull down assays
performed with GST–RCAN3 fusion proteins and 500 μg of HeLa soluble
protein extracts as a source of endogenous Cn. Anti-CnA detected Cn-pulled
down (WB αCnA, upper panel) whereas anti-GST confirmed the integrity of all
fusion proteins analyzed (WB αGST, lower panel). Both gels were run
separately. Lanes 7 and 8 are identical to lanes 5 and 6 respectively to allow us to
compare the GST 177–202 fusion protein (lane 9). One representative
experiment of the three performed, is shown.
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does not bind Cn. Then, the consensus PxIxxT motif, besides
being exclusive to vertebrates, is only present in RCAN1 and
RCAN2 (Fig. 1A, PxIxxT motif in yellow). In contrast, the
RCAN3 177–202 protein retains the ability to bind Cn. Its
amino acid sequence, LGPGEKYELHAGTESTPSVVVH-
VCES, is similar to the RCAN1 CIC motif, previously
described as the minimum region with inhibitory effect towards
NFAT-dependent gene expression [16]. The RCAN3 CIC motif
here described is two amino acids shorter in its N-terminus and
differs from the RCAN1 in three conservative amino acid
changes. Despite this fact, we have named it the RCAN3 CIC
motif. Thus, our results demonstrate that RCAN3 interacts with
Cn. Moreover, the RCAN3 CIC motif is the only sequence
directly involved in Cn binding, as it does not have a consensus
PxIxxT motif, whereas RCAN1 interacts with Cn through the
CIC and the PxIxxT motifs [16].
3.4. RCAN3 inhibits Ca2+-Cn mediated NFAT nuclear
translocation
To establish the functional effects of the RCAN3-Cn
interaction, the GST–RCAN3 fusion proteins analyzed above
(Fig. 2C) were subcloned into the pEGFP vector. In
unstimulated cells, the expression of the full length EGFP–
RCAN3 was detected throughout the cytosol and the nucleus.
Likewise, no change in its subcellular localization pattern was
observed when cells were stimulated with 1 μM Io (data not
shown). These results indicate that the intracellular distribution
of RCAN3 does not depend on Ca2+ signalling.
In resting cells, NFATs are phosphorylated and reside in the
cytosol but upon Ca2+-stimulation, they become dephosphory-
lated by Cn and translocate rapidly to the nucleus [37]. In order
to determine the effect of all EGFP–RCAN3 fusion proteins on
NFAT nuclear localization, we co-expressed both proteins in
COS-7 cells and we analyzed them by confocal microscopy. As
a control, co-expression assays of mock EGFP together with
NFAT-EYFP in unstimulated cells showed NFAT in the cytosol
whereas under stimulatory conditions cells displayed the typical
NFAT speckled pattern in the nucleus (Fig. 3A, red signal). Co-
expression assays involving full length EGFP–RCAN3 show
NFAT clearly retained in the cytosol of Io stimulated cells (Fig.
3A, red signal). Furthermore, truncated EGFP–RCAN3 fusion
proteins including the CIC motif, RCAN3 174–241 and 177–Fig. 3. Ca2+-dependent NFAT nuclear translocation is inhibited by the RCAN3
CIC motif. (A) Full length RCAN3 inhibits NFAT nuclear translocation in
stimulated cells. COS-7 cells were doubly transfected with mock pEGFP or
pEGFP–RCAN3 and pHA-NFAT-EYFP for 16 h and then treated with Io for
10 min. Confocal images from cells expressing mock EGFP or EGFP–
RCAN3 fusion proteins are shown in green whereas NFAT-EYFP is shown in
red. Corresponding merged images are also shown. NFAT-EYFP co-expressed
with mock EGFP under unstimulatory or stimulatory conditions were used as
a control of cytosolic or nuclear NFAT localization, respectively. Images are
representative of three independent experiments. Scale bars are shown. (B)
The RCAN3 CIC motif inhibits NFAT nuclear translocation. Numbers on the
left indicate the corresponding spanning RCAN3 amino acids in each fusion
protein.202, are responsible for the accumulation of NFAT in the
cytosol whereas the fusion proteins lacking this specific Cn
binding region, RCAN3 2–175, 2–143 and 210–241, accumu-
late NFAT in the nucleus (Fig. 3B, compare corresponding red
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NFAT nuclear translocation and this function is mediated
through its CIC motif.
3.5. RCAN3 inhibits the NFAT-dependent cytokine gene
expression
To go one step further we decided to investigate whether the
inhibitory role here described for RCAN3 towards NFAT
nuclear translocation (Fig. 3) could also be affecting NFAT-
dependent downstream expression events. To answer this, we
measured the ability to activate luciferase expression driven by
a promoter including three copies of NFAT binding sites(3xNFAT-luc) in response to calcium stimulation in the presence
of increasing amounts of HA-RCAN3. As seen in Fig. 4A (left
panel), RCAN3 inhibits in a dose-dependent manner the
3xNFAT-reporter plasmid in HEK 293T cells. To determine
the specificity of this RCAN3 inhibitory effect on NFAT-
dependent promoter activation we decided to investigate its
effect on NF-κB dependent gene expression. In this sense, we
performed some experiments where we activated a 6xNF-κB-
luc reporter plasmid with the GFP-p65 (RelA) NF-κB
transcription factor (Fig. 4A, right panel) in the presence or
the absence of RCAN3 protein. Our data show that RCAN3
does not seems to be involved in regulating NF-κB-dependent
gene expression. Thus, our results here suggest that RCAN3
inhibits selectively NFAT-dependent gene expression.
In human T cells, the Ca2+-Cn-NFAT signalling pathway
regulates the transcriptional activation of a wide range of genes,
including several cytokines, which are essential for activating
the immune response. Based on the data shown in Fig. 4A, we
decided to evaluate the RCAN3 effect towards NFAT-dependent
gene expression of several cytokines in Jurkat cells. With this
purpose, we performed a real-time PCR low-density array
analysis to determine IFN-γ, TNF-α, IL-2 and IL-3 gene
expression (Fig. 4B). Data were normalized against the
endogenous control and referred to the calibrator sample (see
Materials and methods). Unstimulated or CsA inhibited EGFP
expressing Jurkat cells showed absence or low cytokine mRNA
levels whereas Io+PMA stimulated cells, considered as the
calibrator sample, showed an increase in gene expression thatFig. 4. RCAN3 inhibits NFAT-dependent gene expression. (A) RCAN3 inhibits
selectively NFAT-dependent gene expression. HEK 293T cells were co-
transfected with pCDNA3-HA or pCDNA3-HA-RCAN3 plasmids, pCMV-
βgal as internal control of transfection and the 3×NFAT-luc (left panel) or the
6×NF-κB-luc (right panel) reporter plasmids, the last one together with pEGFP-
p65 or the pEGFP expression plasmids. Then, cells co-transfected with the
3×NFAT-luc plasmid were stimulated with 1 μM Io, 20 nM PMA (P in figure)
and 10 mM CaCl2 and when indicated, 1 μM CsA was added prior to
stimulation. Results from promoter fold activation of the reporter plasmids are
given as the ratio of relative luciferase activity (luciferase units /β-gal) values
from each sample relative to the corresponding unstimulated control empty
vector. Expression of fusion proteins was confirmed by Western blot analysis.
Values represent the average of three independent wells and standard deviations
are shown. The experiment was performed a minimum of three times with
identical results. (B) Jurkat cells expressing EGFP or EGFP–RCAN3 fusion
proteins were left unstimulated, stimulated with Io and PMA for 3 h 30 min or
inhibited with CsA for 30 min prior to the stimuli, as indicated. cDNA samples
obtained were subjected to real-time PCR analysis using Micro Fluidic cards.
Shown on the top is the graphic representation of the percentage of IFN-γ, TNF-
α, IL-2 and IL-3 cytokine gene expression (see corresponding graphs) relative to
the EGFP Io+P sample, whereas on the bottom, the corresponding numerical
data is summarized. Gene expression values were normalized by the endogenous
control, the GAPDH gene, and then referred to the calibrator, the EGFP Io+P
sample, that was considered as 100% gene expression and used as positive
control of T cell activation. EGFP is omitted in all EGFP–RCAN3 fusion
proteins listed in the table. Numbers beside EGFP–RCAN3 indicate the RCAN3
amino acid sequence that spans each fusion protein. All experiments were
performed at least twice in duplicate. (C) RCAN1 gene expression is
downregulated by RCAN3. Table and graphic representations of the percentage
of RCAN1 gene expression relative to calibrator sample. The RCAN1 cDNA
Taqman probe included on the low-density array detected all RCAN1 transcript
forms.
338 M.C. Mulero et al. / Biochimica et Biophysica Acta 1773 (2007) 330–341was considered as the 100% in all samples (Fig. 4B). Moreover,
full length RCAN3 prevented transcriptional activation of
cytokine genes, which are endogenous downstream targets of
NFAT (Fig. 4B, compare RCAN3 vs. the calibrator sample in
each cytokine). What is more, further analysis with some
EGFP–RCAN3 truncated fusion proteins demonstrates that the
RCAN3 CIC motif is responsible for the significant reduction of
the endogenous cytokine transcription levels analyzed in Jurkat
T cells (Fig. 4B compare 174–241 and 177–202 vs. 2–175 and
the calibrator sample), similar to that reported previously with
the RCAN1 CIC motif [16]. These results suggest that RCAN3
inhibits the NFAT-dependent cytokine gene expression through
its CIC motif.
3.6. RCAN3 inhibits RCAN1 gene expression in Jurkat cells
The RCAN1-4 transcript, but not RCAN1-1, is up-regulated
by the Ca2+-Cn-NFAT signalling pathway whereas the RCAN1-
1 transcript, but not the RCAN1-4, is detected at basal level
[16,35,36]. Given that RCAN3 inhibits NFAT-dependent gene
expression, it should also inhibit RCAN1-4 transcriptional
activation in Ca2+ stimulated Jurkat cells. We analyzed this gene
by real-time PCR in the same low-density array above
indicated. The Taqman probe used in the assay recognized the
C-terminal region common for all RCAN1 transcripts, which
would explain the basal RCAN1 gene expression level detected
in unstimulated or inhibited EGFP samples, probably as a result
of the RCAN1-1 mRNA (Fig. 4C, EGFP - and EGFP CsA+Io
+P). The EGFP Io+PMA sample was considered as the
maximum RCAN1 gene expression level (100%) and as the
calibrator sample. As occurred with cytokines, only EGFP–
RCAN3 fusion proteins including the CIC motif promote a
marked decrease in RCAN1 gene expression (Fig. 4C, compare
full length RCAN3, 174–241 and 177–202 vs. 2–175). Thus,
our results show that the RCAN3 CIC motif inhibits RCAN1
gene expression and we suggest that this down-regulation is due
to the specific inhibition of the endogenous NFAT-dependent
RCAN1-4 transcript in Jurkat cells. The inverse approach was
also carried out with stimulated Jurkat cells overexpressing
EGFP–RCAN1 fusion proteins that include the CIC motif [16].
Basal RCAN3 transcription levels showed no change in EGFP
expressing cells either under stimulatory or inhibitory condi-
tions confirming our previous results (Fig. 2A). Furthermore,
RCAN1 showed no effect towards RCAN3 gene expression
(data not shown).
4. Discussion
Our comparative genomic analysis represents a new insight
into the currently accepted RCANs family concept. Up to now,
authors have considered as RCAN family members those
proteins having the FLISPP motif. However, an exhaustive
analysis in Eukarya has led us to postulate that RCANs in
invertebrates, many fungi and Dictyostelum discoideum, which
include a FLISPP motif, could be considered only as distantly
related RCANs due to their low sequence similarity. Despite
this, a common putative functional role mediated by the FLISPPmotif present in all Eukarya related or not to Cn cannot be
discarded. Interestingly, the RCANs central and C-terminal
regions in vertebrates have a high amino acid sequence
similarity (Supplementary Fig. 1). Usually, this sequence
conservation in proteins reflects common functional roles due
to the establishment of interactions between macromolecules
such as protein-protein and nucleic acid-protein interactions,
among others. In this sense, the high similarity of the RCANs
CIC motif correlates with the functional conservation of the
inhibitory role towards Cn activity, as previously shown for
RCAN1 [16] and for RCAN3 in the present work. Moreover,
the phylogenetic tree suggests that RCAN1, RCAN2 and
RCAN3 in vertebrates are paralogous genes resulting from the
divergence of a single gene. It is also noteworthy that each
RCAN protein in vertebrates shows a characteristic common
and specific amino acid residue conservation (Supplementary
Fig. 1), the functional relevance of which needs to be addressed
[16]. Thus, we suggest that RCANs in vertebrates form a novel
functional RCAN subfamily.
It is also remarkable that NFAT proteins, like RCANs, are
also restricted to vertebrates [38]. However, the Ca2+-
calmodulin-Cn signalling pathway where both proteins are
involved is conserved across species [38]. The higher functional
complexity in vertebrates would implicate the existence of a
wider spectrum of regulators for this particular pathway. In this
sense, the presence of three paralogous genes would further
increase the spectrum of endogenous modulators of Cn activity.
Our work shows for the first time that RCAN3 binds to Cn
and inhibits its phosphatase activity towards NFATs, and
consequently, NFAT-mediated downstream events including
cytokine expression in activated Jurkat T cells.
The present study demonstrates that RCAN3, as well as
RCAN1 and RCAN2 [13–16] physically interacts with Cn. Up
to now, the RCAN3-Cn interaction had only been predicted due
to the high amino acid similarity shared by all human RCANs
but no experimental data had been reported. Recently, it has
been shown that RCAN3 interacts with human cardiac troponin
I [18] by yeast two-hybrid analysis and GST-pull down assays.
Authors hypothesize a functional role for RCAN3 in cardiac
contraction but this point still needs to be experimentally
addressed. Furthermore, cardiac contraction has been shown to
be Ca2+ and Cn-dependent [39].
The interaction of RCAN3 with Cn is exclusively mediated
by its CIC motif, in contrast with RCAN1 that interacts with Cn
through the ELHA (included in the CIC motif) and PxIxxT
motifs, in an independent functional manner [16]. We
hypothesize that the RCAN3 CIC motif interacts with Cn also
through its ELHA motif as has been shown for RCAN1 [16].
Moreover, our comparative genomic analysis and experimental
results suggest that the ELHA motif in RCANs is a Cn-binding
motif functionally conserved in all vertebrates. Thus, we
propose that the RCANs CIC consensus motif in vertebrates
could be defined as LGPG[DE][KQ][AFY]EL[HQ][APT][AG]
T[DEP][ST]TPSVVVHVC[DE][DNS] (Supplementary Fig. 1).
This motif in mammals is defined by the sequence LGPGE-
KYELHA[G-A]T[D-E][S-T]TPSVVVHVC[E-D]S. We can
neither discard nor confirm the functional relevance of the
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consensus motif in vertebrates. It is worth mentioning that
human RCAN3 and RCAN2 CIC motifs are identical whereas
the corresponding RCAN1 motif differs in three conserved
amino acid residue substitutions, G189A, E191D and S192T
(where the amino acid number corresponds to the RCAN3
protein NCB accession no. AAF01684). The functional
importance of these amino acid differences still remains
unknown. Finally, in the last years authors in the field have
hypothesized that RCANs would modulate the Cn-NFAT
signalling pathway through their PxIxxT consensus motif,
probably by interfering with the NFAT PxIxIT Cn-docking site
due to their amino acid sequence similarity. However, our
studies here and previously reported [16] demonstrate that the
CIC motif, but not the PxIxxT one, inhibits the Cn-NFAT
signalling pathway. Moreover, a BLAST analysis performed
with the consensus RCANs CIC motif as a query reveals that
human NFATs do not seem to include either a CIC or a CIC-like
motif in their sequence (data not shown). Furthermore, a
detailed comparison of both proteins showed no protein
homology between the RCAN CIC motifs and the NFAT
PxIxIT and LxVP Cn-binding sites [38]. Thus, the inhibitory
effect of the RCAN CIC motifs on Cn-NFAT signalling seems
not to be due to direct competition with a NFAT Cn-binding
specific sequence.
In contrast with RCAN1, the RCAN3 amino acid sequence
does not include the RCANs PxIxxT consensus motif
described previously [16]. RCAN3 has the QKIAQT sequence
that does not bind Cn under our experimental conditions (Fig.
2D). A mutation analysis of the viral protein A238L PxIxIT
motif has revealed that the substitution of the first Pro residue
completely abolishes the binding of A238L to Cn [40].
Likewise, this Pro residue was considered to be crucial when
optimizing the PxIxIT Cn-docking motif of NFATs from
combinatorial peptide libraries [41]. Taking into account the
amino acidic similarities of the CIC and the PxIxxT motifs
among RCANs, it could be hypothesized that RCAN2 would
interact with Cn through both motifs but it would only inhibit
Cn signalling through CIC, as in RCAN1. However, the
RCAN3-3 isoform described recently [11] that does not
include the C-terminal region of RCAN proteins, and
consequently, does not include the functional CIC motif,
would be expected to not have any effect on the Cn signalling
pathway. Finally, our comparative genomic analysis allows us
to predict that all RCANs in vertebrates and the honeybee
orthologue would interact with Cn due to the presence of one
or both Cn-interacting motifs, ELHA and PxIxxT.
Here we report the inhibitory role of RCAN3, when
overexpressed, on NFAT-mediated signalling, as recently
reported for RCAN1 [16]. This is demonstrated by the
inhibition of NFAT-nuclear translocation, the NFAT-mediated,
but not NF-κB-dependent, luciferase gene expression and
NFAT-dependent cytokine gene expression. Moreover, CIC is
the critical motif in both RCAN proteins, and probably in all
RCANs in vertebrates, for down-regulating cytokine gene
expression. In this sense, minor differences in the level of
inhibition of gene expression for each cytokine are observed.This fact could be due to different synergistic cooperation
between NFAT and AP-1 proteins on DNA composite binding
sites in these cytokine gene promoters, which modulates gene
expression giving rise to different cytokine mRNA amounts
[3,4]. Furthermore, our work also indicates that RCAN3,
probably like all RCANs and Cn inhibitors that modulate their
phosphatase activity towards NFATs, would regulate NFAT-
dependent RCAN1-4 gene expression (Fig. 4C).
It has been reported that post-translational modification of
RCANs, such as phosphorylation, modulates their function in
vivo. In this sense, it has been shown that phosphorylation of
the RCAN1 FLISPP motif modulates Cn activity and RCAN1
protein half-life [19]. Supporting this hypothesis, it has been
recently reported that phosphorylation of this motif is important
for dissociating the RCAN1–Cn complex and establishing the
RCAN1-14-3-3ε/ξ complex, thereby relieving the inhibitory
effect of the exogenously expressed RCAN1 on Cn activity
[42]. Likewise, other RCAN1 phosphorylation sites have been
detected outside the FLISPP motif but the functional relevance
is unknown [19]. Taking advantage of the bioinformatic tools
available, multiple post-translational modification sites along
the RCAN3 sequence can be predicted, including serine-
threonine and tyrosine kinase phosphorylation sites, protease
cleavage sites and protein-protein interaction motifs such as
SH2 or SH3 ligand domains, among others, some of them
within the FLISPP or CIC motifs. The existence or significance
of these post-translational modifications needs to be addressed.
Moreover, our binding assays show that the RCAN3 FLISPP
motif does not directly interact with Cn, it does not inhibit
NFAT nuclear localization or NFAT-dependent gene expression
under our experimental conditions. Finally, as the RCAN3 and
RCAN1 FLISPP motifs have an identical amino acid sequence
we suggest a similar regulation and functional involvement in
this signalling pathway for both proteins.
Inhibition of Tcell activation is themajor drawback of current
immunosuppressive protocols. Nowadays, the most effective
results have been reached with the combined therapy of anti-
calcineurinic and many other drugs [5]. Despite the availability
of multiple agents, their life-long administration provokes
dramatic side effects making it essential to find new molecules.
The characterization herein of the inhibitory role of the RCAN3
CICmotif towards NFATsignalling in Jurkat cells, as previously
described for RCAN1 [16], suggests that this motif could have a
role in the inhibition of T cell activation and, therefore, in the
immune response. However, this topic will be addressed in the
near future. If the CIC motif becomes a novel immunosuppres-
sive tool it could lead to the development of novel therapeutic
agents with less side effects than those currently used in
transplant therapy and the treatment of autoimmune diseases.
Acknowledgments
We thank Dr. J. Aramburu, Dr. A. Bigas, Dr. J.M. Redondo
and Dr. V. Stresing for providing reagents and plasmids.
Furthermore, we are especially grateful to Dr. M. Hueso, Dr. E.
Navarro and Dr. D. Seron for providing the Micro Fluidic cards,
N. Abasolo for RCAN3 cDNA cloning from PBLs, M. Peña for
340 M.C. Mulero et al. / Biochimica et Biophysica Acta 1773 (2007) 330–341RCAN3 constructs and H. Kruyer for the careful revision of this
manuscript. We are especially grateful to A. Bote for his expert
assistance with the cell sorter and Dr. J. Inglés-Esteve for her
advising on luciferase assays. CsA was obtained free from
Novartis. This work was supported by grants from the Instituto
de Salud Carlos III (01/1471, co-financed by the European
FEDER funds), from Fundació La Marató de TV3 (030830),
from the Red de Centros del Instituto de Salud Carlos III (C03/
03 and C03/07) and from the Generalitat de Catalunya (GSR,
2005SGR00018). A.A. was supported by the Fundació
Catalana de Trasplantament and A.S. by the Instituto de Salud
Carlos III (CA05/0090).
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.bbamcr.2006.12.007.References
[1] J. Aramburu, A. Rao, C.B. Klee, Calcineurin: from structure to function,
Curr. Top. Cell. Regul. 36 (2000) 237–295.
[2] M.M. Winslow, J.R. Neilson, G.R. Crabtree, Calcium signalling in
lymphocytes, Curr. Opin. Immunol. 15 (2003) 299–307.
[3] S.H. Im, A. Rao, Activation and deactivation of gene expression by Ca2+/
calcineurin-NFAT-mediated signaling, Mol. Cells 18 (2004) 1–9.
[4] F. Macian, NFAT proteins: key regulators of T-cell development and
function, Nat. Rev., Immunol. 5 (2005) 472–484.
[5] I. Perry, J. Neuberger, Immunosuppression: towards a logical approach in
liver transplantation, Clin. Exp. Immunol. 139 (2005) 2–10.
[6] S. Martinez-Martinez, J.M. Redondo, Inhibitors of the calcineurin/NFAT
pathway, Curr. Med. Chem. 11 (2004) 997–1007.
[7] Z. Hilioti, D.A. Gallagher, S.T. Low-Nam, P. Ramaswamy, P. Gajer, T.J
Kingsbury, C.J. Birchwood, A. Levchenko, K.W. Cunningham, GSK-3
kinases enhance calcineurin signaling by phosphorylation of RCNs, Genes
Dev. 18 (2004) 35–47.
[8] J.J. Fuentes, M.A. Pritchard, A.M. Planas, A. Bosch, I. Ferrer, X. Estivill,
A new human gene from the Down syndrome critical region encodes a
proline-rich protein highly expressed in fetal brain and heart, Hum. Mol.
Genet. 4 (1995) 1935–1944.
[9] J.J. Fuentes, M.A. Pritchard, X. Estivill, Genomic organization, alternative
splicing, and expression patterns of the DSCR1 (Down syndrome
candidate region 1) gene, Genomics 44 (1997) 358–361.
[10] T. Miyazaki, Y. Kanou, Y. Murata, S. Ohmori, T. Niwa, K. Maeda, H.
Yamamura, H. Seo, Molecular cloning of a novel thyroid hormone-
responsive gene, ZAKI-4, in human skin fibroblasts, J. Biol. Chem. 271
(1996) 14567–14571.
[11] P. Strippoli, L. Lenzi, M. Petrini, P. Carinci, M. Zannotti, A new gene
family including DSCR1 (Down Syndrome Candidate Region 1) and
ZAKI-4: characterization from yeast to human and identification of
DSCR1-like 2, a novel human member (DSCR1L2), Genomics 64 (2000)
252–263.
[12] G. Ermak, C.D. Harris, D. Battocchio, K.J. Davies, RCAN1 (DSCR1 or
Adapt78) stimulates expression of GSK-3beta, FEBS J. 273 (2006)
2100–2109.
[13] B. Rothermel, R.B. Vega, J. Yang, H. Wu, R. Bassel-Duby, R.S. Williams,
A protein encoded within the Down syndrome critical region is enriched in
striated muscles and inhibits calcineurin signaling, J. Biol. Chem. 275
(2000) 8719–8725.
[14] J.J. Fuentes, L. Genesca, T.J. Kingsbury, K.W. Cunningham, M. Perez-
Riba, X. Estivill, S. de la Luna, DSCR1, overexpressed in Down
syndrome, is an inhibitor of calcineurin-mediated signaling pathways,
Hum. Mol. Genet. 9 (2000) 1681–1690.[15] X. Cao, F. Kambe, T. Miyazaki, D. Sarkar, S. Ohmori, H. Seo, Novel
human ZAKI-4 isoforms: hormonal and tissue-specific regulation and
function as calcineurin inhibitors, Biochem. J. 367 (2002) 459–466.
[16] A. Aubareda, M.C. Mulero, M. Perez-Riba, Functional characterization of
the calcipressin 1 motif that suppresses calcineurin-mediated NFAT-
dependent cytokine gene expression in human T cells, Cell Signal. 18
(2006) 1430–1438.
[17] P. Strippoli, M. Petrini, L. Lenzi, P. Carinci, M. Zannotti, The murine
DSCR1-like (Down syndrome candidate region 1) gene family: conserved
synteny with the human orthologous genes, Gene 257 (2000) 223–232.
[18] S. Canaider, F. Facchin, C. Griffoni, R. Casadei, L. Vitale, L. Lenzi, F.
Frabetti, P. D'Addabbo, P. Carinci, M. Zannotti, P. Strippoli, Proteins
encoded by human Down syndrome critical region gene 1-like 2
(DSCR1L2) mRNA and by a novel DSCR1L2 mRNA isoform interact
with cardiac troponin I (TNNI3), Gene 372 (2006) 128–136.
[19] L. Genesca, A. Aubareda, J.J. Fuentes, X. Estivill, S. De La Luna, M.
Perez-Riba, Phosphorylation of calcipressin 1 increases its ability to inhibit
calcineurin and decreases calcipressin half-life, Biochem. J. 374 (2003)
567–575.
[20] B. Sanna, E.B. Brandt, R.A. Kaiser, P. Pfluger, S.A. Witt, T.R. Kimball, E.
van Rooij, L.J. De Windt, M.E. Rothenberg, M.H. Tschop, S.C. Benoit,
J.D. Molkentin, Modulatory calcineurin-interacting proteins 1 and 2
function as calcineurin facilitators in vivo, Proc. Natl. Acad. Sci. U. S. A.
103 (2006) 7327–7332.
[21] S.F. Altschul, T.L. Madden, A.A. Schaffer, J. Zhang, Z. Zhang, W. Miller,
D.J. Lipman, Gapped BLAST and PSI-BLAST: a new generation of
protein database search programs, Nucleic Acids Res. 25 (1997)
3389–3402.
[22] J.D. Thompson, T.J. Gibson, F. Plewniak, F. Jeanmougin, D.G. Higgins,
The CLUSTAL_X windows interface: flexible strategies for multiple
sequence alignment aided by quality analysis tools, Nucleic Acids Res. 25
(1997) 4876–4882.
[23] S. Kumar, K. Tamura, M. Nei, MEGA3: integrated software for molecular
evolutionary genetics analysis and sequence alignment, Brief Bioinform. 5
(2004) 150–163.
[24] K.B. Nicholas, H.B. Nicholas, D.W. Deerfield II, EMBnet 4 (1997) 1–4.
[25] F. Abascal, R. Zardoya, D. Posada, ProtTest: selection of best-fit models of
protein evolution, Bioinformatics 21 (2005) 2104–2105.
[26] A. Drummond, K. Strimmer, PAL: an object-oriented programming library
for molecular evolution and phylogenetics, Bioinformatics 17 (2001)
662–663.
[27] S. Guindon, O. Gascuel, A simple, fast, and accurate algorithm to
estimate large phylogenies by maximum likelihood, Syst. Biol. 52 (2003)
696–704.
[28] A. Rodriguez, S. Martinez-Martinez, M.D. Lopez-Maderuelo, I. Ortega-
Perez, J.M. Redondo, The linker region joining the catalytic and the
regulatory domains of CnA is essential for binding to NFAT, J. Biol. Chem.
280 (2005) 9980–9984.
[29] C. Luo, K.T. Shaw, A. Raghavan, J. Aramburu, F. Garcia-Cozar, B.A.
Perrino, P.G. Hogan, A. Rao, Interaction of calcineurin with a domain of
the transcription factor NFAT1 that controls nuclear import, Proc. Natl.
Acad. Sci. U. S. A. 93 (1996) 8907–8912.
[30] C. Aguilera, V. Fernández-Majada, J. Inglés-Esteve, V. Rodilla, A. Bigas,
L. Espinosa, Efficient nuclear export of p65-IkappaBalpha complexes
requires 14-3-3 proteins, J. Cell. Sci. 119 (2006) 3695–3704.
[31] C. Chen, H. Okayama, High-efficiency transformation of mammalian cells
by plasmid DNA, Mol. Cell. Biol. 7 (1987) 2745–2752.
[32] F.W. Kluxen, H. Lubbert, Maximal expression of recombinant cDNAs in
COS cells for use in expression cloning, Anal. Biochem. 208 (1993)
352–356.
[33] T.J. Kingsbury, K.W. Cunningham, A conserved family of calcineurin
regulators, Genes Dev. 14 (2000) 1595–1604.
[34] A. Rao, C. Luo, P.G. Hogan, Transcription factors of the NFAT family:
regulation and function, Annu. Rev. Immunol. 15 (1997) 707–747.
[35] J. Yang, B. Rothermel, R.B. Vega, N. Frey, T.A. McKinsey, E.N. Olson, R.
Bassel-Duby, R.S. Williams, Independent signals control expression of the
calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles,
Circ. Res. 87 (2000) E61–E68.
341M.C. Mulero et al. / Biochimica et Biophysica Acta 1773 (2007) 330–341[36] A.V. Narayan, R. Stadel, A.B. Hahn, D.L. Bhoiwala, G. Cornielle, E.
Sarazin, I. Koleilat, D.R. Crawford, Redox response of the endogenous
calcineurin inhibitor Adapt78, Free Radic. Biol. Med. 39 (2005) 719–727.
[37] C. Loh, K.T. Shaw, J. Carew, J.P. Viola, C. Luo, B.A. Perrino, A. Rao,
Calcineurin binds the transcription factor NFAT1 and reversibly regulates
its activity, J. Biol. Chem. 271 (1996) 10884–10891.
[38] P.G. Hogan, L. Chen, J. Nardone, A. Rao, Transcriptional regulation by
calcium, calcineurin, and NFAT, Genes Dev. 17 (2003) 2205–2232.
[39] B.J. Wilkins, J.D. Molkentin, Calcium-calcineurin signaling in the
regulation of cardiac hypertrophy, Biochem. Biophys. Res. Commun.
322 (2004) 1178–1191.[40] J.E. Miskin, C.C. Abrams, L.K. Dixon, African swine fever virus protein
A238L interacts with the cellular phosphatase calcineurin via a binding
domain similar to that of NFAT, J. Virol. 74 (2000) 9412–9420.
[41] J. Aramburu, M.B. Yaffe, C. Lopez-Rodriguez, L.C. Cantley, P.G.
Hogan, A. Rao, Affinity-driven peptide selection of an NFAT
inhibitor more selective than cyclosporin A, Science 285 (1999)
2129–2133.
[42] S. Abbasi, J.D. Lee, B. Su, X. Chen, J.L. Alcon, J. Yang, R.E. Kellems, Y.
Xia, Protein kinase-mediated regulation of calcineurin through the
phosphorylation of modulatory calcineurin-interacting protein 1, J. Biol.
Chem. 281 (2006) 7717–7726.
